Skip to main content

Non-thyroidal Hypothyroidism

  • Chapter
  • First Online:
Management of Patients with Pseudo-Endocrine Disorders
  • 515 Accesses

Abstract

Hypothyroidism is characterized by deficient tissue thyroid hormone action overwhelmingly due to deficient endogenous thyroid hormone synthesis and secretion by the thyroid. Overt and subclinical hypothyroidism may or may not be associated with nonspecific symptoms that have become identified as consistent with the presence of hypothyroidism but are by no means specific to deficient thyroid hormone action. The diagnosis of hypothyroidism has evolved from a clinical impression based on symptoms (which some practitioners continue to deem sufficient) and now should also include biochemical evidence of thyroid dysfunction as indicated by contemporary guidelines for clinical practice. Once accurately diagnosed, hypothyroidism is expected to be readily treated by replacing thyroid hormone. The clinical management of hypothyroidism is assumed to be simple and direct. It is also assumed by some that symptoms persisting in patients diagnosed as hypothyroid are due to ongoing deficiency in thyroid hormone action on the impacted tissues of the body. But why would we assume that the initiation of thyroid hormone in subjects with symptoms “consistent with hypothyroidism” who are not hypothyroid should result in resolution of these non-thyroid complaints? This discussion examines potential pitfalls in diagnosis and how patients are selected for treatment with thyroid replacement and questions the safety and outcomes of thyroid hormone replacement therapy. Additionally, this review explores alternative explanations for symptoms that may result in the initial assessment of thyroid function tests and the diagnosis of hypothyroidism and offers an approach to persistent symptoms in those on thyroid hormone replacement presumed to be hypothyroid.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med. 1997;12(9):544–50.

    Article  CAS  Google Scholar 

  2. Canaris GJ, Manowitz NR, Mayor GH, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526–34.

    Article  CAS  Google Scholar 

  3. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200–35. https://doi.org/10.1089/thy.2012.0205.

    Article  CAS  PubMed  Google Scholar 

  4. Carle A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Andersen S, Laurberg P. Hypothyroid symptoms fail to predict thyroid insufficiency in old people: a population-based case-control study. Am J Med. 2016;129(10):1082–92. https://doi.org/10.1016/j.amjmed.2016.06.013.

    Article  PubMed  Google Scholar 

  5. Bould H, Panicker V, Kessler D, Durant C, Lewis G, Dayan C, Evans J. Investigation of thyroid dysfunction is more likely in patients with high psychological morbidity. Fam Pract. 2012;29(2):163–7. https://doi.org/10.1093/fampra/cmr059.

    Article  CAS  PubMed  Google Scholar 

  6. Saravanan P, Chau W-F, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on “adequate” doses of L-thyroxine: results of a large, controlled community-based questionaire study. Clin Endocrinol. 2002;57:577–85.

    Article  CAS  Google Scholar 

  7. Pollock MA, Sturrock A, Marshall K, Davidson KM, Kelly CJG, McMahon AD, McLaren EH. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomized double blind placebo controlled crossover trial. Br Med J. 2001;323(20 October):891–5.

    Article  CAS  Google Scholar 

  8. Taylor PN, Iqbal A, Minassian C, Sayers A, Draman MS, Greenwood R, Hamilton W, Okosieme O, Panicker V, Thomas SL, Dayan C. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 2014;174(1):32–9. https://doi.org/10.1001/jamainternmed.2013.11312.

    Article  PubMed  Google Scholar 

  9. Stott DJ, Rodondi N, Kearney PM, Ford I, Westendorp RGJ, Mooijaart SP, Sattar N, Aubert CE, Aujesky D, Bauer DC, Baumgartner C, Blum MR, Browne JP, Byrne S, Collet TH, Dekkers OM, den Elzen WPJ, Du Puy RS, Ellis G, Feller M, Floriani C, Hendry K, Hurley C, Jukema JW, Kean S, Kelly M, Krebs D, Langhorne P, McCarthy G, McCarthy V, McConnachie A, McDade M, Messow M, O'Flynn A, O’Riordan D, Poortvliet RKE, Quinn TJ, Russell A, Sinnott C, Smit JWA, Van Dorland HA, Walsh KA, Walsh EK, Watt T, Wilson R, Gussekloo J. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;376(26):2534–44. https://doi.org/10.1056/NEJMoa1603825.

    Article  CAS  PubMed  Google Scholar 

  10. Somwaru LL, Rariy CM, Arnold AM, Cappola AR. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab. 2012;97(6):1962–9. https://doi.org/10.1210/jc.2011-3047.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 1995;43:55–68.

    Article  CAS  Google Scholar 

  12. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3–126. https://doi.org/10.1089/105072503321086962.

    Article  PubMed  Google Scholar 

  13. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA. Serum TSH, T4, and thyroid antibodies in the United States population(1988 to 1994): National Health and Nutrition Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489–99.

    Article  CAS  Google Scholar 

  14. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007). doi:jc.2007-1499 [pii];92(12):4575–82. https://doi.org/10.1210/jc.2007-1499.

    Article  CAS  PubMed  Google Scholar 

  15. Ehrenkranz J, Bach PR, Snow GL, Schneider A, Lee JL, Ilstrup S, Bennett ST, Benvenga S. Circadian and circannual rhythms in thyroid hormones: determining the TSH and free T4 reference intervals based upon time of day, age, and sex. Thyroid. 2015;25(8):954–61. https://doi.org/10.1089/thy.2014.0589.

    Article  CAS  PubMed  Google Scholar 

  16. Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM, Wilson SG, O’Leary PC, Walsh JP. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab. 2012;97(5):1554–62. https://doi.org/10.1210/jc.2011-3020.

    Article  CAS  PubMed  Google Scholar 

  17. Fontes R, Coeli CR, Aguiar F, Vaisman M. Reference interval of thyroid stimulating hormone and free thyroxine in a reference population over 60 years old and in very old subjects (over 80 years): comparison to young subjects. Thyroid Res. 2013;6(1):13. https://doi.org/10.1186/1756-6614-6-13. 1756-6614-6-13 [pii].

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Waring AC, Arnold AM, Newman AB, Buzkova P, Hirsch C, Cappola AR. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab. 2012;97(11):3944–50. https://doi.org/10.1210/jc.2012-2481.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Konno N. Comparison between the thyrotropin response to thyrotropin-releasing hormone in summer and that in winter in normal subjects. Endocrinol Jpn. 1978;25(6):635–9.

    Article  CAS  Google Scholar 

  20. Kim TH, Kim KW, Ahn HY, Choi HS, Won H, Choi Y, Cho SW, Moon JH, Yi KH, Park DJ, Park KS, Jang HC, Kim SY, Park YJ. Effect of seasonal changes on the transition between subclinical hypothyroid and euthyroid status. J Clin Endocrinol Metab. 2013;98(8):3420–9. https://doi.org/10.1210/jc.2013-1607. jc.2013-1607 [pii].

    Article  CAS  PubMed  Google Scholar 

  21. Konno N, Morikawa K. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine. J Clin Endocrinol Metab. 1982;54(6):1118–24. https://doi.org/10.1210/jcem-54-6-1118.

    Article  CAS  PubMed  Google Scholar 

  22. Gullo D, Latina A, Frasca F, Squatrito S, Belfiore A, Vigneri R. Seasonal variations in TSH serum levels in athyreotic patients under L-thyroxine replacement monotherapy. Clin Endocrinol. 2017;87(2):207–15. https://doi.org/10.1111/cen.13351.

    Article  CAS  Google Scholar 

  23. Catli G, Anik A, Unver Tuhan H, Bober E, Abaci A. The effect of L-thyroxine treatment on hypothyroid symptom scores and lipid profile in children with subclinical hypothyroidism. J Clin Res Pediatr Endocrinol. 2014;6(4):238–44. https://doi.org/10.4274/Jcrpe.1594.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Stott DJ, Rodondi N, Bauer DC. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;377(14):e20. https://doi.org/10.1056/NEJMc1709989.

    Article  PubMed  Google Scholar 

  25. Massolt ET, van der Windt M, Korevaar TI, Kam BL, Burger JW, Franssen GJ, Lehmphul I, Kohrle J, Visser WE, Peeters RP. Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid Cancer. Clin Endocrinol. 2016;85:781. https://doi.org/10.1111/cen.13101.

    Article  CAS  Google Scholar 

  26. Hedman C, Djarv T, Strang P, Lundgren CI. Effect of thyroid-related symptoms on long-term quality of life in patients with differentiated thyroid carcinoma: a population-based study in Sweden. Thyroid. 2017;27(8):1034–42. https://doi.org/10.1089/thy.2016.0604.

    Article  CAS  PubMed  Google Scholar 

  27. Alhashemi A, Jones JM, Goldstein DP, Mina DS, Thabane L, Sabiston CM, Chang EK, Brierley JD, Sawka AM. An exploratory study of fatigue and physical activity in Canadian thyroid cancer patients. Thyroid. 2017;27(9):1156–63. https://doi.org/10.1089/thy.2016.0541. 10.1089/thy.2016.0541 [pii]

    Article  PubMed  Google Scholar 

  28. Ladenson PW. Psychological wellbeing in patients. Clin Endocrinol. 2002;57(5):575–6. doi:1682 [pii]

    Article  Google Scholar 

  29. Saravanan P, Visser TJ, Dayan CM. Psychological well-being correlates with free thyroxine but not free 3,5,3′-triiodothyronine levels in patients on thyroid hormone replacement. J Clin Endocrinol Metab. 2006;91(9):3389–93. jc.2006-0414 [pii] 10.1210/jc.2006-0414.

    Article  CAS  Google Scholar 

  30. Nygaard B, Jensen EW, Kvetny J, Jarlov A, Faber J. Effect of combination therapy with thyroxine (T4) and 3,5,3′-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur J Endocrinol. 2009;161(6):895–902. https://doi.org/10.1530/EJE-09-0542. EJE-09-0542 [pii].

    Article  CAS  PubMed  Google Scholar 

  31. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP. 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1(2):55–71. https://doi.org/10.1159/000339444. etj-0001-0055 [pii].

    Article  PubMed  PubMed Central  Google Scholar 

  32. Medici BB, la Cour JL, Michaelsson LF, Faber JO, Nygaard B. Neither baseline nor changes in serum triiodothyronine during levothyroxine/Liothyronine combination therapy predict a positive response to this treatment modality in hypothyroid patients with persistent symptoms. Eur Thyroid J. 2017;6(2):89–93. https://doi.org/10.1159/000454878. etj-0006-0089 [pii].

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95(1):186–93. https://doi.org/10.1210/jc.2009-1625. jc.2009-1625 [pii].

    Article  CAS  PubMed  Google Scholar 

  34. Mammen JS, McGready J, Oxman R, Chia CW, Ladenson PW, Simonsick EM. Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults: findings from the Baltimore longitudinal study of aging. Thyroid. 2015;25(9):979–86. https://doi.org/10.1089/thy.2015.0180.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PWF, Benjamin EJ, D'Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52.

    Article  CAS  Google Scholar 

  36. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracey RP, Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295(9):1033–41.

    Article  CAS  Google Scholar 

  37. Bauer DC, Ettinger B, Nevitt MC, Stone KL. Group, S.o.O.F.R.: risk for fracture in women with low levels of thyroid-stimulating hormone. Ann Intern Med. 2001;134(7):561–8.

    Article  CAS  Google Scholar 

  38. Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, Wirth CD, Peeters RP, Asvold BO, den Elzen WP, Luben RN, Imaizumi M, Bremner AP, Gogakos A, Eastell R, Kearney PM, Strotmeyer ES, Wallace ER, Hoff M, Ceresini G, Rivadeneira F, Uitterlinden AG, Stott DJ, Westendorp RG, Khaw KT, Langhammer A, Ferrucci L, Gussekloo J, Williams GR, Walsh JP, Juni P, Aujesky D, Rodondi N. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055–65. https://doi.org/10.1001/jama.2015.5161.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Okosieme O, Gilbert J, Abraham P, Boelaert K, Dayan C, Gurnell M, Leese G, McCabe C, Perros P, Smith V, Williams G, Vanderpump M. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin Endocrinol. 2016;84(6):799–808. https://doi.org/10.1111/cen.12824.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James V. Hennessey .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hennessey, J.V. (2019). Non-thyroidal Hypothyroidism. In: McDermott, M. (eds) Management of Patients with Pseudo-Endocrine Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-22720-3_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-22720-3_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-22719-7

  • Online ISBN: 978-3-030-22720-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics